Abstract
Biological models of psychopathology emphasize the relationship between a specific constellation of symptoms and an underlying abnormality in physiologic function. Such disorders may be treated with medication and other approaches that are thought to directly alter the underlying biological abnormality (Andrea-sen, 1984). Modern biological models of psychopathology may be traced to the work of Emile Kraepelin and other European psychiatrists of the late nineteenth and early twentieth centuries, who developed nosological distinctions between major psychiatric disorders, as had been done with major systematic disorders (Andreasen, 1984). Although Kraepelin focused on the development of a diagnostic nosology (with little emphasis on etiology), he believed that disorders such as schizophrenia were caused by underlying biologic factors (Arieti, 1974). In recent years, biological models of psychopathology have increased in popularity, and research has intensified in biologically oriented therapies. Based on animal models, inference from responses to medication, and advanced research methods using sophisticated laboratory imaging techniques and biochemical assays, several hypothesis have been suggested to explain the possible biological basis of certain mental disorders. The present chapter provides an introduction to the biological basis of psychopathology, and presents the reader with the conceptual basis of contemporary biological models, including: genetic, biochemical, neuroanatomical, and neuroendocrinological.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders, 3rd Edition, Revised. Washington, DC: Author.
Andreasen, N. C. (1984). The broken brain: The biological revolution in psychiatry. New York: Harper and Row.
Arieti, S. (1974). Interpretation of schizophrenia. New York: Basic Books.
Baldessarini, R. J. (1989). Current status of antidepressants: Clinical pharmacology and therapy Journal of Clinical Pharmacology, 50, 117–126.
Barlow, D. H. (1988). Anxiety and its disorders: The nature of anxiety and panic. New York: Guilford Press.
Baxter, L. R., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta, J. C., Alazraki, A., Selin, C. E., Ferng, H. K., & Munford, P. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49, 681–689.
Bebbington, P. E., Brugha, T., MacCarthy, B., Potter, J., Sturt, E., Wykes, T., Katz, R., & Mcguffin, P. (1988). The Camberwell Collaborative Depression Study I. Depressed probands: Adversity and the form of depression. British Journal of Psychiatry, 152, 754–765.
Bertelsen, A. (1985). Controversies and consistencies in psychiatric genetics. Acta Psychiatrica Scandin-vica, 71, (Suppl 319), 61–75.
Braddock, M. P. (1986). The dexamethasone suppression test: Fact and artifact. British Journal of Psychiatry, 148, 363 – 374.
Brunello, N., Barbaccia, M. L., Chuang, D., & Costa, E. (1982). Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: Permissive role of serotonergic axioms. Neuropharmacology, 21, 1145–1149.
Bryden, M. P., & Ley, R. G. (1983). Right hemispheric involvement in the perception and expression of emotion in normal humans. In K. M. Heilman & P. Satz (Eds.), Neuropsychology of human emotion, (pp. 6–44). New York: Guilford Press.
Buchsbaum, M. S. (1990). The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16, 379–389.
Bunney, W. E., & Davis, J. M. (1965). Norepinephrine in depressive reactions: A review. Archives of General Psychiatry, 13, 483–495.
Charlton, B. G., & Ferner, N. (1989). Hypothalamo-pituitary-adrenal axis abnormalities in depression: A review and a model. Psychological Medicine, 19, 331–336.
Cinciripini, P. M. (1986a). Cognitive stress and cardiovascular reactivity I: Relationship to hypertension. American Heart Journal, 112, 1044–1050.
Cinciripini, P. M. (1986b). Cognitive stress and cardiovascular reactivity II: Relationship to atherosclerosis, arrhythmias, and cognitive control. American Heart Journal, 112, 1051–1065.
Cox, T. (1988). Psychobiological factors in stress and health. In S. Fisher, & J. Reason (Eds.), Handbook of life stress, cognition, and health, (pp. 603–625). New York: John Wiley and Sons.
Dalgleish, T., & Watts, F. N. (1990). Biases of attention and memory in disorders of anxiety and depression. Clinical Psychology Review, 10, 589–604.
Damasio, A. R., & Van Hoesen, G. W. (1983). Emotional disturbances associated with focal lesions of the limbic frontal lobe. In K. M. Heilmann & P. Satz (Eds.), Neuropsychology of human emotion, (pp. 85–110). New York: Guilford Press.
Egeland, J. A., Gerhard, D. S., Pauls, D. L., Sussex, J. N., Kidd, K. K., Allen, C. R., Hostetter, A. M., & Housman, D. E. (1987). Bipolar affective disorders linked to DNA markers on chromosome 11. Nature, 325, 783–787.
Eison, M. S. (1990). Serotonin: A common neurobiologic substrate in anxiety and depression. Journal of Clinical Psychopharmacology, 10, 26–30.
Farkas, T., Wolf, A. P., Jaeger, J., Brodie, J. D., Christman, D. R., & Fowler, J. S. (1984). Regional brain glucose metabolism in chronic schizophrenia: A position emission transaxial tomographic study. Archives of General Psychiatry, 41, 293–300.
Gardner, R. (in press). Sociobiology and its applications to psychiatry. In H. Kaplan & B. J. Sadock (Eds.) Comprehensive textbook of psychiatry. New York: Williams and Wilkins Publishing.
Garza-Trevino, E. S., Volkow, N. D., Cancro, R., & Contreras, S. (1990). Neurobiology of schizophrenia. Hospital and Community Psychiatry, 41, 971–980.
Gainotti, G. (1972). Emotional behavior and hemispheric side of the lesion. Cortex, 9, 41–55.
Gainotti, G. (1989). Disorders of emotions and affect in patients with unilateral brain damage. In F. Boller & J. Grafman (Eds.), Handbook of neuropsychology (Vol. 3, pp. 345–361). New York: Elsevier Science Publishers.
Goldstein, S., & Halbreich, U. (1987). Hormones and stress. In C. B. Nemeroff, & P.T. Loosen (Eds.), Handbook of Clinical Psychoneuroendocrinology, pp. 460–469. New York: Guilford Press.
Gottesman, I., & Shields, J. (1973). Genetic theorizing and schizophrenia. British Journal of Psychiatry, 122, 15–20.
Gusella, J. E, Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Xanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y, Young, A. B., Shoulson, I., Bonilla, E., & Martin, J. B. (1983). A polymorphic DNS marker genetically linked to Huntington’s disease. Nature, 306, 234–238.
Hans, S., & Marcus, J. (1987). A process model for the development of schizophrenia. Psychiatry, 50, 361–370.
Heilman, K. M., Bowers, D., & Valenstein, E. (1985). Emotional disorders associated with neurological diseases. In K. M. Heilman & E. Valenstein (Eds.), Clinical neuropsychology, (pp. 377–402). New York: Oxford University Press.
Hodgkinson, S., Sherrington, R., Gurling, H., Marchbanks, R., Reeders, S., Mallett, J., McInnis, M., Pertursson, H., & Brynjolfsson, J. (1987). Molecular genetic evidence for heterogeneity in manic depression. Nature, 325, 805–806.
Holroyd, K. A., & Lazarus, R. S. (1982). Stress, coping, and somatic adaptation. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects (pp. 21–33). New York: Free Press.
Kandel, E. R. (1985). Brain and behavior. In E. R. Kandel & J. H. Schwartz (Eds.), Principles of neuroscience (2nd ed.), (pp. 3–13). New York: Elsevier Press.
Kendler, K. S., & Eaves, L. J. (1986). Models for the joint effect of genotype and environment on liability to psychiatric illness. American Journal of Psychiatry, 143, 279–289.
Kendler, K. S., Kessler, R. C., Heath, A. C., Neale, M. C., & Eaves, L. J. (1991). Coping: A genetic epidemiological investigation. Psychological Medicine, 21, 337–346.
Kluver, H., & Bucy, P. C. (1937). “Psychic blindness” and other symptoms following bilateral temporal lobectomy in rhesus monkeys. American Journal of Physiology, 259, 352–353.
Lloyd, K. G., Morselli, P. L., & Bartholini, G. (1987). GABA and affective disorders. Medical Biology, 65, 159–165.
Loehlin, J. C., Willerman, L., & Horn, J. M. (1988). Human behavior genetics. Annual Review of Psychology, 39, 101–133.
Luria, A. R. (1973). The working brain: An introduction to neuropsychology. New York: Basic Books.
Maas, J. W. (1975). Biogenic amines and depression. Archives of General Psychiatry, 32, 1357–1361.
Macchi, G. (1989). Anatomical substrate of emotional reactions. In E Boller & J. Grafman (Eds.), Handbook of neuropsychology, (Vol. 3, pp. 283–303). New York: Elsevier Press.
Martin, M. B., Owen, C. M., & Morihsa, J. M. (1987). An overview of neurotransmitters and neuroreceptors. In R. E. Hales & S. C. Yudofsky (Eds.), Textbook of neuropsychiatry (pp. 55–85). Washington, DC: American Psychiatric Press.
Meltzer, H. Y. (1987). Biological studies in schizophrenia. Schizophrenia Bulletin, 13, 77–97.
Meltzer, H. Y. (1990). Role of serotonin in depression. Annals of the New York Academy of Sciences, 600, 486–497.
Morley, J. E., & Krahn, D. D. (1987). Endocrinology for the psychiatrist. In C. B. Nemeroff & P. T. Loosen, (Eds.). Handbook of clinical psychoneuroendocrinology (pp. 3–37). New York: Guilford Press.
Murray, D. J. (1983). A history of western psychology. Englewood Cliffs, NJ: Prentice-Hall.
Papez, J. W. (1937). A proposed mechanism of emotion. Archives of Neurological Psychiatry, 38, 725–743.
Plomin, R. (1986). Development, genetics, and psychology. Hillsdale, NJ: Lawrence Erlbaum Associates.
Plomin, R. (1989). Environment and genes: Determinants of behavior. American Psychologist, 44, 105–11.
Plomin, R., & Rende, R. (1991). Human behavioral genetics. Annual Review of Psychology, 42, 161–190.
Plomin, R., Rende, R., & Rutter, M. (1991). Quantitative genetics and developmental psychopathology. In D. Cicchetti & S. Toth (Eds.), Internalizing and externalizing expressions of dysfunction: Rochester Symposium on Developmental Psychopathology, (pp. 155–202). Hillsdale, NJ: Erlbaum.
Prior, J. C., & Sulser, F. (1991). Evolution of the monoamine hypothesis of depression. In R. Horton & C. Katona (Eds.), Biological aspects of affective disorders, (pp. 77–94). New York: Academic Press.
Rainer, J. D. (1985). Genetics and psychiatry. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry, (pp. 25–42). Baltimore: Williams and Wilkins.
Rende, R., & Plomin, R. (1992). Diathesis-stress models of psychopathology: A quantitative genetic perspective. Applied & Preventative Psychology, 1, 177–182.
Richelson, E. (1990). Antidepressants and brain neuro-chemistry. Mayo Clinic Proceedings, 65, 1227–1236.
Rose, R. M. (1984). Overview of endocrinology of stress. In G. M. Brown, S. H. Koslow, & S. Reichlin (Eds.), Neuroendocrinology and psychiatric disorder, (pp. 95–122). New York: Raven Press.
Rosenman, R. H., & Chesney, M. A. (1982). Stress, type A behavior, and coronary disease. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects, (pp. 547–563). New York: Free Press.
Rosenzweig, M. R. (1984). Experience, memory, and the brain. American Psychologist, 39, 356–376.
Rutter, M. (1991). Nature, nurture, and psychopathology: A new look at an old topic. Development and Psychopathology, 3, 125–136.
Rutter, M., & Pickles, A. (1991). Person-environment interactions: Concepts, mechanisms, and implications for data analysis. In T. D. Wachs & R. Plomin (Eds.), Conceptualization and measurement of organism-environment interaction, (pp. 105–141). Washington, DC: American Psychological Association.
Sachar, E. J., Asnis, G., Swami Nathan, R., Halbreich, U., Tabrizi, M., & Halpern, F. S. (1980). Dextroamphetamine and Cortisol in depression: Morning plasma Cortisol levels suppressed. Archives of General Psychiatry, 37, 755–767.
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorder: A review of supporting evidence. American Journal of Psychiatry, 122, 509–522.
Selye, H. (1982). History and present status of the stress concept. In L. Goldberger & S. Breznitz (Eds.), Handbook of stress: Theoretical and clinical aspects, (pp. 7–17). New York: Free Press.
Sherrington, R., Brynjolfsson, J., Petursson, H., Potter, M., Dudleston, K., Barraclough, B., Wasmuth, J., Dobbs, M., & Gurlin, H. (1988). Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature, 336, 164–167.
Snyder, S. H. (1985). Basic science of psychopharmacology. In H. I. Kaplan & B. J. Saddock (Eds.), Comprehensive textbook of psychiatry, (pp. 42–156). Baltimore, MD: Williams and Wilkins.
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. (1974). Drugs, neurotransmitters, and schizophrenia. Science, 184, 1243–1253.
Sommi, R. W., Crismon, M. L., & Bowden, C. L. (1987). Fluoxetine: A serotonin-specific, second generation antidepressant. Pharmacotherapy, 7, 1–14.
Sopolski, R. M. (1990). Stress in the wild. Scientific American, 262, 116–123.
Squire, L. R. (1985). Memory and brain. New York: Oxford University Press.
Strauss, E. (1983). Perception of emotional words. Neuropsychologia, 21, 99–103.
Stuss, D. T., & Benson, D. E. (1986). The frontal lobes. New York: Raven Press.
Sulser, F. (1983). Mode of action of antidepressant drugs. Journal of Clinical Psychiatry, 44, 14–20.
Syvalahti, E. (1987). Monoaminergic mechanisms in affective disorders. Medical Biology, 65, 89–96.
Tienari, P., Lahti, I., Sorri, A., Naarala, M., Moring, J., & Wahlberg, K. (1989). The Finnish Adoptive Family Study of Schizophrenia: Possible joint effects of genetic vulnerability and family environment. British Journal of Psychiatry, 155, 29–32.
Tsuang, M. T., & Faraone, S. V. (1990). The genetics of mood disorders. Baltimore: Johns Hopkins University Press.
Vandenberg, S. G., Singer, S. M., & Pauls, D. L. (1986). The heredity of behavior disorders in adults and children. New York: Plenum Press.
Vetulani, J., Stawarz, R. J., Dingell, J. V., & Sulser, E. (1976). A possible common mechanism of action of antidepressant treatments: Reduction in the sensitivity of noradrenergic cyclic AMP generating system in the rat limbic cortex. Scandanavica, 78, 618–621.
Vita, A., Sacchetti, E., Valvassori, G., & Gazzulio, C. L. (1988). Brain morphology in schizophrenia: A two to five year CT scan follow up study Acta Psychiatrica Scandanavica, 78, 618–621.
Wallace, J. E., & MacCrimmon, D. J. (1989). Hyperthyroidism: Cognitive and emotional factors. In G. Holmes (Ed.), Psychoneuroendocrinology: Brain, behavior, and hormonal interactions (pp. 323–442). New York: Springer Verlag.
Weissman, M. M., Merikangas, K. R., John, K., Wickramaratne, P., Prussoff, B. A., & Kidd, K. K. (1986). Family-genetic studies of psychiatric disorders. Archives of General Psychiatry, 43, 1104–1116.
Westenberg, H. G. M., & Verhoeven, W. M. A. (1988). CSF monoamine metabolites in patients and controls: Support for a bimodal distribution in major affective disorders. Acta Psychiatrica Scandanavica, 78, 541–549.
Weinberger, D. R., Wagner, R. L., & Wyatt, R. J. (1983). Neuropathological studies of schizophrenia: A selective review. Schizophrenia Bulletin, 9, 193–212.
White, R., & Lalouel, J. (1988). Chromosome mapping with DNA markers. Scientific American, 258, 40–50.
Worley, F. F., Baraban, J. M., & Snyder, S. H. (1987). Beyond receptors: Second messenger systems in brain. Annals of Neurology, 21, 217–229.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Plenum Press, New York
About this chapter
Cite this chapter
Wilde, M.C., Cinciripini, P.M. (1994). Biological Model. In: Van Hasselt, V.B., Hersen, M. (eds) Advanced Abnormal Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0345-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0345-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0347-4
Online ISBN: 978-1-4757-0345-0
eBook Packages: Springer Book Archive